<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Hoth Therapeutics' revenue and expenses trend in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/9/2025 00:19am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Hoth Therapeutics experienced a revenue of $1.32 million and incurred R&amp;D expenses of $2.38 million in Q4 2024, resulting in a negative net income for the period.


|code|Ticker|Name|Date|R&amp;D Expenses|Total Revenue|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|HOTH|HOTH.O|Hoth Therapeutics|2024 Q1|465896||-2040783|186|
|HOTH|HOTH.O|Hoth Therapeutics|2024 Q2|566335||-1632474|186|
|HOTH|HOTH.O|Hoth Therapeutics|2024 Q3|897510||-2132053|186|
|HOTH|HOTH.O|Hoth Therapeutics|2024 Q4|1319355||-2382990|186|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:W,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:d,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:H,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Hoth Therapeutics' revenue and expenses trend in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Hoth Therapeutics' revenue and expenses trend in Q4 2024?\",\"user_id\":\"dp10691952\",\"user_name\":\"\",\"trace_id\":\"8c344568-12d6-4246-a8c9-d4ab0f250d02\",\"session_id\":\"8c344568-12d6-4246-a8c9-d4ab0f250d02\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue[20241231]|R&D Expenses[20241231]|Net Income[20241231]|Report End Date|\n|---|---|---|---|---|---|---|---|\n|HOTH|Hoth Therapeutics|$0.95|6.06%||$1.32 million|-$2.38 million|20241231|\n",query_data:{number:h,title:I,query_type:j,condition:a,model_sql:X,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:d}}}],answer_chain_name:Y,agent_mode:Z,native_answer:a,come_from:a,text_answer:W,trace_id:i,cost:18458,event_names:a,question:g,fallback_type:_,input_type:$,fall_back_reason:{fall_back_type:_,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:i,first_return_cost:3746,cache_type:"no_cache",question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:J,remote_svc:o,slots:[],answer_type:H,user_id:z,skill_name:K},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:z,question:g,source:o,raw_question:g,version:"3.4.1",action_name:K,nlu:{entity:[{type:aa,value:q,market:k}]},output_time:J,deep_research:c,deep_thinking:c,agent_mode:Z},extra:{}},{answer_path:A,section:{id:B,info_texts:["Thinking"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:A,section:{id:B,info_texts:["Querying Stock: HOTH Revenue (Q4 2024), R&D Expenses (Q4 2024), SG&A Expenses (Q4 2024), Net Income (Q4 2024)"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:I,thought:"The user seeks to analyze Hoth Therapeutics' Q4 2024 revenue and expense trends. I should focus on its Q4 2024 revenue, R&D expenses, SG&A expenses, and net income data. I will use FinQuery for the data mentioned above."}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:A,section:{id:B,info_texts:["Generating Answer"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:D,voice_txt:"H",text_answer:ab,rich_text:ab,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:2000,info_texts:[],show_type:D,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:I,query_type:j,trace_data:a,index:h,model_sql:X,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:d},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:D,voice_txt:".\n\n",text_answer:ac,rich_text:ac,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:t,market_id:k,name:m,domain:aa},pos:d,section_id:s,txt:m,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:ad,choice:[],result_page:{components:[{uuid:"20af6c432cf42042",config:{score:116,show_type:ae,scoreRuleNames:"value_unit;data_size;",showDataZoom:b,show_type_id:131,title:"分组柱状图",render:{x:u,y:[E,F]},title_config:{config:{display:b,display2:c,txt_style:d,url:a},data:{h1:af,h2:a},show_type:L}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:M,key:M,label:"hq_code",source:N,type:f},{domain:v,feKey:O,index_name:O,key:O,label:M,origin_index:"stock code",source:N,type:f,unit:a},{domain:v,feKey:P,index_name:P,key:P,label:"name",origin_index:"stock name",source:N,type:f,unit:a},{feKey:u,index_name:u,key:u,label:"date",origin_index:u,type:"DATE"},{domain:v,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:Q,unit:R},{domain:v,feKey:S,index_name:S,key:S,label:a,source:a,timestamp:a,type:Q,unit:R},{domain:v,feKey:F,index_name:F,key:F,label:a,source:a,timestamp:a,type:Q,unit:R},{index_name:ag,key:ag,type:f}],condition:"[{\"sonSize\":6,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL HOTH.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"HOTH.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":4,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@R\\u0026D Expenses\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Net Income\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{"Net Income":-2040783,code:t,"R&D Expenses":465896,Ticker:q,market_code:k,Date:"2024 Q1",Name:m},{"Net Income":-1632474,code:t,"R&D Expenses":566335,Ticker:q,market_code:k,Date:"2024 Q2",Name:m},{"Net Income":-2132053,code:t,"R&D Expenses":897510,Ticker:q,market_code:k,Date:"2024 Q3",Name:m},{"Net Income":-2382990,code:t,"R&D Expenses":1319355,Ticker:q,market_code:k,Date:"2024 Q4",Name:m}],meta:{extra:{}},row_count:h,status_code:d,status_msg:"ok"},category:"generic",chart_type:"groupedBar",show_type:ae,title_config:{config:{display:b,display2:c,txt_style:d,url:a},data:{h1:af,h2:a},show_type:L},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"bar3\",\"uuid\":\"20af6c432cf42042\"}]"},render_for:T},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"55e31e41-a89a-4ade-ac14-8dca7cb704fe"},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:D,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:A,section:{id:B,info_texts:["Completed"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ad,choice:[{display_text:w,query_text:w,trace_info:{item_id:"a608ccfa0b61a7b65b5919c12a7c5eab",item_type:n,item_name:w,rec_info:ah}},{display_text:x,query_text:x,trace_info:{item_id:"b3fa82f7d327260f2280ba02b5db7859",item_type:n,item_name:x,rec_info:ai}},{display_text:y,query_text:y,trace_info:{item_id:"13167f93198d3f3bc4b1c6da00ae7831",item_type:n,item_name:y,rec_info:aj}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:L,data:{h1:a,h2:a},config:{display:c,txt_style:d,type:"1",display2:c,url:a}},request_config:[{source_type:ak,related_name:al}],puuid:U,tag:a,category:"custom",uuid:am}],global:{urp_static_data:[{name:al,value:{status_code:d,columns:[{type:f,index_name:an,key:an},{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar}],datas:[{send_text:w,item_type:n,rec_info:ah,display_text:w,rec_reason:a},{send_text:x,item_type:n,rec_info:ai,display_text:x,rec_reason:a},{send_text:y,item_type:n,rec_info:aj,display_text:y,rec_reason:a}],dataSize:ak,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:as,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:G,"min-height":"100%",position:at,height:G},isMaterial:c,id:as,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:d,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:V,componentUuid:am,script:[{name:au,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:V,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:V},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:G,position:at,height:G},isMaterial:b,_id:19,id:au,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:T,voice_txt:a,tracking_info:{},uuid:U},order:{is_auto:c,render_for:T,chart_type:"command",puuid:U}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:K,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:H,answer_chain_name:Y},is_deep_research:c,deep_thinking:c,create_time:1746721188809},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:av,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:av,client_ip:a,question:g,user_id:z,user_name:a,trace_id:i,session_id:i,source:o,input_type:$}}],userId:z,userName:a,startTime:J,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:d,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-hoth-therapeutics-revenue-and-expenses-trend-in-q4-2024-750498\u002F",config:{_app:{basePath:aw,assetsPath:aw,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,0,"other\u002FopenAnswer","STR","How did Hoth Therapeutics' revenue and expenses trend in Q4 2024?",1,"8c344568-12d6-4246-a8c9-d4ab0f250d02","intusstock","186","signal","Hoth Therapeutics","llm_generated","ths_ainvest_lite_web",null,"HOTH.O",999,2001,"HOTH","Date","abs_国际美股领域","What were Hoth Therapeutics' revenue figures for Q4 2024?","What were the key cost drivers for Hoth Therapeutics in Q4 2024?","What was the net loss or profit reported by Hoth Therapeutics in Q4 2024?","dp10691952","progress\u002Fsearching_for",1000,"searching_for","rich_text","R&D Expenses","Net Income","auto","agent","HOTH Revenue (Q4 2024), R&D Expenses (Q4 2024), SG&A Expenses (Q4 2024), Net Income (Q4 2024)",1746721170351,"inspect stocks","title1","code","fixed_index","Ticker","Name","DOUBLE","USD","Total Revenue","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Hoth Therapeutics experienced a revenue of $1.32 million and incurred R&D expenses of $2.38 million in Q4 2024, resulting in a negative net income for the period.\n\n\n|code|Ticker|Name|Date|R&D Expenses|Total Revenue|Net Income|market_code|\n|---|---|---|---|---|---|---|---|\n|HOTH|HOTH.O|Hoth Therapeutics|2024 Q1|465896||-2040783|186|\n|HOTH|HOTH.O|Hoth Therapeutics|2024 Q2|566335||-1632474|186|\n|HOTH|HOTH.O|Hoth Therapeutics|2024 Q3|897510||-2132053|186|\n|HOTH|HOTH.O|Hoth Therapeutics|2024 Q4|1319355||-2382990|186|\n\n","select   stock_code,   total_revenue,   r_d_expenses,   net_income from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'HOTH.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","Hoth Therapeutics experienced a revenue of $1.32 million and incurred R&D expenses of $2.38 million in Q4 2024, resulting in a negative net income for the period[^1]",".\n\n\n``` visual\n{\"uuid\":\"55e31e41-a89a-4ade-ac14-8dca7cb704fe\"}\n```","result_page","bar3","HOTH R&D Expenses, Net Income","market_code","2+679_496_21_554+0+0+8c344568-12d6-4246-a8c9-d4ab0f250d02+a608ccfa0b61a7b65b5919c12a7c5eab+llm_generated+aimeTagAnalysis+0+0.016319623216986656+1","2+679_496_21_554+0+0+8c344568-12d6-4246-a8c9-d4ab0f250d02+b3fa82f7d327260f2280ba02b5db7859+llm_generated+aimeTagAnalysis+0+0.01191122829914093+2","2+679_496_21_554+0+0+8c344568-12d6-4246-a8c9-d4ab0f250d02+13167f93198d3f3bc4b1c6da00ae7831+llm_generated+aimeTagAnalysis+0+0.010735410265624523+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>